A series of assays were performed on CRC patients (n = 14) and age-matched controls (n = 11) to determine whether removal of CD25hi cells altered the immune response to recall antigens and the tumor-associated antigen 5T4. This evidence concerns the gene TPBG and colorectal carcinoma.